These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 33192984)

  • 1. Thin-Slice Magnetic Resonance Imaging-Based Radiomics Signature Predicts Chromosomal 1p/19q Co-deletion Status in Grade II and III Gliomas.
    Kong Z; Jiang C; Zhang Y; Liu S; Liu D; Liu Z; Chen W; Liu P; Yang T; Lyu Y; Zhao D; You H; Wang Y; Ma W; Feng F
    Front Neurol; 2020; 11():551771. PubMed ID: 33192984
    [No Abstract]   [Full Text] [Related]  

  • 2. Amide proton transfer weighted and diffusion weighted imaging based radiomics classification algorithm for predicting 1p/19q co-deletion status in low grade gliomas.
    Ma A; Yan X; Qu Y; Wen H; Zou X; Liu X; Lu M; Mo J; Wen Z
    BMC Med Imaging; 2024 Apr; 24(1):85. PubMed ID: 38600452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conventional magnetic resonance imaging-based radiomic signature predicts telomerase reverse transcriptase promoter mutation status in grade II and III gliomas.
    Jiang C; Kong Z; Zhang Y; Liu S; Liu Z; Chen W; Liu P; Liu D; Wang Y; Lyu Y; Zhao D; Wang Y; You H; Feng F; Ma W
    Neuroradiology; 2020 Jul; 62(7):803-813. PubMed ID: 32239241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive genotype prediction of chromosome 1p/19q co-deletion by development and validation of an MRI-based radiomics signature in lower-grade gliomas.
    Han Y; Xie Z; Zang Y; Zhang S; Gu D; Zhou M; Gevaert O; Wei J; Li C; Chen H; Du J; Liu Z; Dong D; Tian J; Zhou D
    J Neurooncol; 2018 Nov; 140(2):297-306. PubMed ID: 30097822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and external validation of a non-invasive molecular status predictor of chromosome 1p/19q co-deletion based on MRI radiomics analysis of Low Grade Glioma patients.
    Casale R; Lavrova E; Sanduleanu S; Woodruff HC; Lambin P
    Eur J Radiol; 2021 Jun; 139():109678. PubMed ID: 33848780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fusion Radiomics Features from Conventional MRI Predict MGMT Promoter Methylation Status in Lower Grade Gliomas.
    Jiang C; Kong Z; Liu S; Feng S; Zhang Y; Zhu R; Chen W; Wang Y; Lyu Y; You H; Zhao D; Wang R; Wang Y; Ma W; Feng F
    Eur J Radiol; 2019 Dec; 121():108714. PubMed ID: 31704598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative Radiomics Analysis of 1p/19q Status in WHO Grade II Gliomas.
    Fan Z; Sun Z; Fang S; Li Y; Liu X; Liang Y; Liu Y; Zhou C; Zhu Q; Zhang H; Li T; Li S; Jiang T; Wang Y; Wang L
    Front Oncol; 2021; 11():616740. PubMed ID: 34295805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T2-FLAIR mismatch sign and machine learning-based multiparametric MRI radiomics in predicting IDH mutant 1p/19q non-co-deleted diffuse lower-grade gliomas.
    Tang WT; Su CQ; Lin J; Xia ZW; Lu SS; Hong XN
    Clin Radiol; 2024 May; 79(5):e750-e758. PubMed ID: 38360515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI radiomics analysis of molecular alterations in low-grade gliomas.
    Shofty B; Artzi M; Ben Bashat D; Liberman G; Haim O; Kashanian A; Bokstein F; Blumenthal DT; Ram Z; Shahar T
    Int J Comput Assist Radiol Surg; 2018 Apr; 13(4):563-571. PubMed ID: 29270916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiparametric MR radiomics in brain glioma: models comparation to predict biomarker status.
    He J; Ren J; Niu G; Liu A; Wu Q; Xie S; Ma X; Li B; Wang P; Shen J; Wu J; Gao Y
    BMC Med Imaging; 2022 Aug; 22(1):137. PubMed ID: 35931979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prediction of 1p/19q codeletion status in diffuse lower-grade glioma using multimodal MRI radiomics].
    Lu M; Qu Y; Ma A; Zhu J; Zou X; Lin G; Li Y; Liu X; Wen Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jun; 43(6):1023-1028. PubMed ID: 37439176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An MRI-based radiomics signature as a pretreatment noninvasive predictor of overall survival and chemotherapeutic benefits in lower-grade gliomas.
    Wang J; Zheng X; Zhang J; Xue H; Wang L; Jing R; Chen S; Che F; Heng X; Li G; Xue F
    Eur Radiol; 2021 Apr; 31(4):1785-1794. PubMed ID: 33409797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment MR imaging radiomics signatures for response prediction to induction chemotherapy in patients with nasopharyngeal carcinoma.
    Wang G; He L; Yuan C; Huang Y; Liu Z; Liang C
    Eur J Radiol; 2018 Jan; 98():100-106. PubMed ID: 29279146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting the 1p/19q Codeletion Status of Presumed Low-Grade Glioma with an Externally Validated Machine Learning Algorithm.
    van der Voort SR; Incekara F; Wijnenga MMJ; Kapas G; Gardeniers M; Schouten JW; Starmans MPA; Nandoe Tewarie R; Lycklama GJ; French PJ; Dubbink HJ; van den Bent MJ; Vincent AJPE; Niessen WJ; Klein S; Smits M
    Clin Cancer Res; 2019 Dec; 25(24):7455-7462. PubMed ID: 31548344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Cui Y; Yang X; Shi Z; Yang Z; Du X; Zhao Z; Cheng X
    Eur Radiol; 2019 Mar; 29(3):1211-1220. PubMed ID: 30128616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Validation of an Efficient MRI Radiomics Signature for Improving the Predictive Performance of 1p/19q Co-Deletion in Lower-Grade Gliomas.
    Kha QH; Le VH; Hung TNK; Le NQK
    Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Triple-Classification Radiomics Model for the Differentiation of Primary Chordoma, Giant Cell Tumor, and Metastatic Tumor of Sacrum Based on T2-Weighted and Contrast-Enhanced T1-Weighted MRI.
    Yin P; Mao N; Zhao C; Wu J; Chen L; Hong N
    J Magn Reson Imaging; 2019 Mar; 49(3):752-759. PubMed ID: 30430686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiogenomics of lower-grade gliomas: machine learning-based MRI texture analysis for predicting 1p/19q codeletion status.
    Kocak B; Durmaz ES; Ates E; Sel I; Turgut Gunes S; Kaya OK; Zeynalova A; Kilickesmez O
    Eur Radiol; 2020 Feb; 30(2):877-886. PubMed ID: 31691122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging based radiomics signature for the preoperative discrimination of stage I-II and III-IV head and neck squamous cell carcinoma.
    Ren J; Tian J; Yuan Y; Dong D; Li X; Shi Y; Tao X
    Eur J Radiol; 2018 Sep; 106():1-6. PubMed ID: 30150029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion.
    Kawaguchi T; Sonoda Y; Shibahara I; Saito R; Kanamori M; Kumabe T; Tominaga T
    J Neurooncol; 2016 Sep; 129(3):505-514. PubMed ID: 27401154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.